Pesquisa

Edição
Título
Autores
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.
Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form
Shadrichev F.
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M., Biryukova E., Zilov A.
Farmakoterapiya, mestnye i dopolnitel'nye metody lecheniya pri sindrome diabeticheskoy stopy
Obolenskiy V., Nikitin V., Leval' P., Ermolova D., Molochnikov A., Ermolov A.
HOW TO OVERCOME THE EFFECTS OF "HYPERGLYCEMIC" MEMORY?
Biryukova E., V Biryukova Y.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T., Demicheva T.
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I., Makova A., Demidova I., Makova A.
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
Is it possible to stop the diabetes epidemic?
Verbovoy A., Dolgikh Y., Verbovaya N.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
Features of urine microflora in diabetic patients
Chikanova A., Khamnuyeva L., Karnoukhova O., Sudakova N., Tokareva N.
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
Gusenbekova D., Ametov A., Butaeva S.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI
Arbatskaya N.
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M., Derevyanchenko M.
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Dorofeeva L.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A., Vorozhtsova E., Orlova T.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.
OSTEOPOROZ: TOChKA ZRENIYa ENDOKRINOLOGA
Biryukova E.
ROLE OF GLYCATION END-PRODUCTS BLOCKERS IN THE DEVELOPMENT OF NEUROLOGIC COMPLICATIONS OF DIABETES MELLITUS
Podachina S., Podachina S.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I., Romantsova T., Glinkina I., Romantsova T.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E., pl?midmagidsid Y.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.
Common bean (Phaseolus vulgaris L.)/
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M., Antsiferov M.
LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa
Petunina N.
New directions of drugs Milgamma and Milgamma compositum use in the diabetes mellitus
Den'gin V., Dengin V.
Diabetic foot syndrome: approaches to treatment of infection
Privol'nev V., Privolnev V.
301 - 354 de 354 resultados << < 1 2 3 4 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies